云顶新耀(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01952 云顶新耀

交易中 05-09 15:56:49

48.250

+0.700

+1.47%

最高48.750	最低46.900	成交量290.60万
今开47.950	昨收47.550	日振幅3.89%
总市值157.78亿	流通市值157.78亿	总股本3.27亿
成交额1.39亿	换手率0.89%	流通股本3.27亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01952","market":"HK","secType":"STK","nameCN":"云顶新耀","latestPrice":48.25,"timestamp":1746777406484,"preClose":47.55,"halted":0,"volume":2906000,"delay":0,"floatShares":327000000,"shares":327000000,"eps":-3.4828681843807843,"marketStatus":"交易中","change":0.7,"latestTime":"05-09 15:56:49","open":47.95,"high":48.75,"low":46.9,"amount":139145675,"amplitude":0.038906,"askPrice":48.3,"askSize":8500,"bidPrice":48.2,"bidSize":23500,"shortable":3,"etf":0,"ttmEps":-3.4828681843807843,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746778200000},"marketStatusCode":2,"adr":0,"listingDate":1602172800000,"exchange":"SEHK","adjPreClose":47.55,"openAndCloseTimeList":[[1746754200000,1746763200000],[1746766800000,1746777600000]],"volumeRatio":0.878041,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01952","defaultTab":"news","newsList":[{"id":"2534930111","title":"国内首个！云顶新耀IgA肾病对因治疗药“布地奈德肠溶胶囊”获完全批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2534930111","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534930111?lang=zh_cn&edition=full","pubTime":"2025-05-09 06:02","pubTimestamp":1746741739,"startTime":"0","endTime":"0","summary":"布地奈德肠溶胶囊的完全批准基于全球III期临床试验NefIgArd研究的完整数据。此次取消限制后，所有具有疾病进展风险的IgA肾病患者均可使用，覆盖人群大幅扩大。这一举措显著提升了药物可及性，尤其考虑到IgA肾病需长期管理，医保支持对患者坚持治疗至关重要。对云顶新耀而言，布地奈德肠溶胶囊的完全批准是其商业化进程的关键一步。布地奈德肠溶胶囊的临床价值已获国际权威指南认可。尽管布地奈德肠溶胶囊疗效显著，但仍存在局限性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509063213a47745c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509063213a47745c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01952","BK1583","BK1161"],"gpt_icon":0},{"id":"2533069306","title":"云顶新耀05月07日遭主力抛售51.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533069306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533069306?lang=zh_cn&edition=full","pubTime":"2025-05-07 16:15","pubTimestamp":1746605708,"startTime":"0","endTime":"0","summary":"05月07日, 云顶新耀股价跌2.13%，报收48.30元，成交金额2.4亿元，换手率1.52%，振幅6.59%，量比1.13。云顶新耀今日主力资金净流出51.2万元，连续4日净流出，上一交易日主力净流出1030.3万元。该股近5个交易日上涨8.07%，主力资金累计净流出828.1万元；近20日主力资金累计净流出5312.0万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507170612a4751f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507170612a4751f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01952","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2533640333","title":"云顶新耀耐赋康获准 成为中国首个且唯一IgA肾病对因治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2533640333","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533640333?lang=zh_cn&edition=full","pubTime":"2025-05-07 12:45","pubTimestamp":1746593100,"startTime":"0","endTime":"0","summary":"5月7日，云顶新耀发布公告，宣布耐赋康已获得中国国家药品监督管理局的完全批准，用于治疗具有疾病进展风险的原发性IgA肾病成人患者。这一批准取消了对蛋白尿水平的限制，使耐赋康成为中国首个且唯一获得完全批准的IgA肾病对因治疗药物。耐赋康是口服靶向布地奈德迟释胶囊，专为IgA肾病患者设计，具有良好的安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507125004975184d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507125004975184d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01952","BK1161","BK1574"],"gpt_icon":0},{"id":"2533107576","title":"商业化全面提速 云顶新耀（01952）耐赋康®在中国完全获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2533107576","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533107576?lang=zh_cn&edition=full","pubTime":"2025-05-07 10:41","pubTimestamp":1746585686,"startTime":"0","endTime":"0","summary":"5月7日，港股创新药企云顶新耀宣布，耐赋康正式获得国家药品监督管理局同意，由附条件批准转为完全批准，用于治疗具有疾病进展风险的原发性免疫球蛋白A肾病成人患者，以减少肾功能损失。耐赋康完全获批，基于3期临床2年完整优异的肾功能保护数据，并取消了对蛋白尿水平的限制。云顶新耀财报显示，截至2024年底，耐赋康已成功覆盖全国600-700余家核心医院，触达60%以上的目标患者群体。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"商业化全面提速 云顶新耀（01952）耐赋康®在中国完全获批","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01952","BK1161","BK1583"],"gpt_icon":0},{"id":"2533615865","title":"云顶新耀(01952)：耐赋康®获国家药监局完全批准用于治疗Ig A肾病","url":"https://stock-news.laohu8.com/highlight/detail?id=2533615865","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533615865?lang=zh_cn&edition=full","pubTime":"2025-05-07 09:04","pubTimestamp":1746579892,"startTime":"0","endTime":"0","summary":"此次完全批准意味着耐赋康成为中国首个且唯一获得中国药监局完全批准的Ig A肾病对因治疗药物。此次获批是基于Nef Ig Ard III期临床研究的完整数据。IgA肾病是一种进行性慢性自身免疫性疾病。这种在肾脏中的沉积可导致进行性肾脏损伤，并可能导致终末期肾病。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/NjM0MjIyYjU0Mjc1NmY0ZmZkYzFjMzM4MDk2MjY3MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NjM0MjIyYjU0Mjc1NmY0ZmZkYzFjMzM4MDk2MjY3MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1958203","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01952","BK1583","BK1574"],"gpt_icon":0},{"id":"2533643047","title":"云顶新耀“布地奈德肠溶胶囊”在国内获完全批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2533643047","media":"医药魔方Info","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533643047?lang=zh_cn&edition=full","pubTime":"2025-05-07 08:29","pubTimestamp":1746577777,"startTime":"0","endTime":"0","summary":"5月7日，云顶新耀宣布其布地奈德肠溶胶囊正式获得国家药品监督管理局同意，由附条件批准转为完全批准，取消了对蛋白尿水平的限制，用于治疗具有疾病进展风险的原发性免疫球蛋白A肾病成人患者，以减少肾功能损失。此次完全批准，意味着耐赋康成为国内首个且唯一获得NMPA完全批准的IgA肾病对因治疗药物。耐赋康是口服靶向布地奈德迟释胶囊，是靶向肠道的黏膜免疫调节剂。该协议于2022年3月扩展，将韩国纳入云顶新耀的授权许可范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507110749a474c69b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507110749a474c69b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","01952","BK1161"],"gpt_icon":0},{"id":"2533569450","title":"云顶新耀(01952)：耐赋康获得中国国家药品监督管理局完全批准用于治疗具有疾病进展风险的原发性IgA肾病成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2533569450","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533569450?lang=zh_cn&edition=full","pubTime":"2025-05-07 07:12","pubTimestamp":1746573120,"startTime":"0","endTime":"0","summary":"云顶新耀发布公告，耐赋康已获中国国家药品监督管理局的完全批准，取消了对蛋白尿水平的限制，用于治疗具有疾病进展风险的原发性IgA肾病成人患者。此次完全批准意味着耐赋康成为中国首个且唯一获得中国药监局完全批准的IgA肾病对因治疗药物。这项研究为期2年，包括9个月的耐赋康或安慰剂治疗期，随后是15个月的停药随访期。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-07/doc-inevssqn1568968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1161","01952","BK1583"],"gpt_icon":0},{"id":"2531084404","title":"每日卖空追踪 | 云顶新耀-B 04月30日卖空量成交52.05万股，卖空比例为9.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531084404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531084404?lang=zh_cn&edition=full","pubTime":"2025-04-30 17:49","pubTimestamp":1746006562,"startTime":"0","endTime":"0","summary":"云顶新耀-B北京时间04月30日，涨0.61%，卖空量成交52.05万股，较上一交易日减少15.43%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430175446a6cea849&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430175446a6cea849&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1583","01952"],"gpt_icon":0},{"id":"2531748291","title":"云顶新耀(01952)新药伊曲莫德获中国香港卫生署批准上市 用于治疗中重度活动性溃疡性结肠炎","url":"https://stock-news.laohu8.com/highlight/detail?id=2531748291","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531748291?lang=zh_cn&edition=full","pubTime":"2025-04-30 08:08","pubTimestamp":1745971739,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月30日，云顶新耀今日宣布，中国香港卫生署已正式批准伊曲莫德用于治疗中重度活动性溃疡性结肠炎成人患者的新药上市许可申请。2024年12月，伊曲莫德的新药上市申请获得中国国家药品监督管理局的正式受理。此前，伊曲莫德已被纳入2024年美国胃肠病学协会临床实践指南, 作为溃疡性结肠炎的一线治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"云顶新耀(01952)新药伊曲莫德获中国香港卫生署批准上市 用于治疗中重度活动性溃疡性结肠炎","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01952","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2531760828","title":"格隆汇沽空预警榜 | 4月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=2531760828","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531760828?lang=zh_cn&edition=full","pubTime":"2025-04-30 02:15","pubTimestamp":1745950500,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日大市沽空比例为18.16%，过去两个月大市日均沽空比例为17.82%。其中，工银南方国债、X南方中创业-R、安硕亚洲除日-U沽空比率排名前三位，分别为100.00%、100.00%、100.00%。盈富基金、恒生中国企业、南方恒生科技的沽空金额排名前三位，分别为28.07亿、27.62亿、25.14亿。华夏以太币、华夏比特币、汽车街的偏离值排名前三位，分别为6.21、5.57、3.79。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/30021550023529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1611","03111","80700","80388","89988","09042","81211","HBBD.SI","LU0329678337.USD","LU0348825331.USD","LU1880383366.USD","01952","03042","09388","00272","002594","HYDD.SI","03189","83042","03033","03199","BYDDY","HXXD.SI","02273","83147","03072","09399","81810","HTCD.SI","02443","HMTD.SI","02828","LU0329678170.USD","09899","07522","LU0823038988.USD","02800","03046"],"gpt_icon":1},{"id":"2531757262","title":"云顶新耀-B盘中异动 下午盘股价大涨5.04%报46.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531757262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531757262?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:15","pubTimestamp":1745910912,"startTime":"0","endTime":"0","summary":"2025年04月29日下午盘15时15分，云顶新耀-B股票出现异动，股价急速拉升5.04%。截至发稿，该股报46.850港元/股，成交量368.7万股，换手率1.13%，振幅4.82%。资金方面，该股资金流入8540.89万港元，流出5229.59万港元。云顶新耀-B股票所在的生物技术行业中，整体涨幅为2.70%。云顶新耀作为沪深港通下港股通标的，此次股份简称“B”标记的移除，表明公司在市值和收入等达主板上市企业要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429151513aa2c7de7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429151513aa2c7de7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","01952","BK1161"],"gpt_icon":1},{"id":"2530849253","title":"港股异动 | 生物科技股普跌，康方生物跌近12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530849253","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530849253?lang=zh_cn&edition=full","pubTime":"2025-04-28 13:42","pubTimestamp":1745818948,"startTime":"0","endTime":"0","summary":"格隆汇4月28日｜港股市场此前多日上涨的生物科技股今日普跌，其中，康方生物大跌超11%，云康集团跌超6%，宜明昂科-B跌超5%，云顶新耀-B跌超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/76824cd4c5b97eaacdaab63d96995a28","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/76824cd4c5b97eaacdaab63d96995a28"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504281024289747df2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504281024289747df2f&s=b","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","LU1794554557.SGD","01541","IE00B5MMRT66.SGD","01952","LU0348784397.USD","LU0417516571.SGD","IE00BPRC5H50.USD","BK1161","LU1720050803.USD","09926","IE00B543WZ88.USD","BK1574","LU0348783233.USD"],"gpt_icon":0},{"id":"2530991574","title":"云顶新耀-B盘中异动 大幅下挫5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530991574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530991574?lang=zh_cn&edition=full","pubTime":"2025-04-28 09:36","pubTimestamp":1745804182,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘09时36分，云顶新耀-B股票出现波动，股价大幅下挫5.27%。云顶新耀-B股票所在的生物技术行业中，整体跌幅为2.50%。消息层面，截至09时36分，《云顶新耀：移除股份“B”标记 业绩高增长》资讯为影响云顶新耀-B的重要信息。云顶新耀作为沪深港通下港股通标的，此次股份简称“B”标记的移除，表明公司在市值和收入等达主板上市企业要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093622a469c07c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093622a469c07c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01952","BK1574","BK1161","BK1583"],"gpt_icon":0},{"id":"2530932564","title":"云顶新耀：移除股份“B”标记 业绩高增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2530932564","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530932564?lang=zh_cn&edition=full","pubTime":"2025-04-28 08:03","pubTimestamp":1745798625,"startTime":"0","endTime":"0","summary":"【4 月 28 日，云顶新耀宣布重大变动！】2025 年 4 月 28 日，云顶新耀是专注创新药研发等的生物制药公司。其已满足港交所上市规则第 8.05 条的市值/收益要求，股份简称中的“B”标记于 2025 年 4 月 22 日获批移除，相关变更自 2025 年 5 月 2 日生效。云顶新耀作为沪深港通下港股通标的，此次股份简称“B”标记的移除，表明公司在市值和收入等达主板上市企业要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042809100694e52a7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042809100694e52a7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01952","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2530462350","title":"云顶新耀宣布于5月2日起正式从股份简称中移除“B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2530462350","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530462350?lang=zh_cn&edition=full","pubTime":"2025-04-28 07:38","pubTimestamp":1745797130,"startTime":"0","endTime":"0","summary":"中国上海—2025年4月28日—云顶新耀是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司，今日宣布，公司已满足香港联交所上市规则第8.05条的市值/收益要求，其股份简称中的“B”标记于2025年4月22日获得批准移除，相关变更将自2025年5月2日起正式生效。云顶新耀作为沪深港通下港股通标的，股份简称“B”标记的成功移除，标志着公司在市值和收入等方面已达到主板上市企业要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/28073849934308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1574","BK1583","01952"],"gpt_icon":0},{"id":"2530098799","title":"云顶新耀-B04月25日主力净流入2415万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2530098799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530098799?lang=zh_cn&edition=full","pubTime":"2025-04-25 16:17","pubTimestamp":1745569037,"startTime":"0","endTime":"0","summary":"04月25日, 云顶新耀-B股价涨2.16%，报收47.40元，成交金额3.53亿元，换手率2.24%，振幅5.60%，量比1.35。云顶新耀-B今日主力资金净流入2415万元，上一交易日主力净流出3470万元。该股近5个交易日上涨1.72%，主力资金累计净流出1984万元；近20日主力资金累计净流出3612万元，其中净流出天数为10日。该股主力净额占比0.16%，港股市场排名22/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171021a6c7cfb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171021a6c7cfb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01952","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2530097633","title":"云顶新耀-B：5 月 2 日起简称将变更 1952 不变","url":"https://stock-news.laohu8.com/highlight/detail?id=2530097633","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530097633?lang=zh_cn&edition=full","pubTime":"2025-04-25 13:33","pubTimestamp":1745559225,"startTime":"0","endTime":"0","summary":"【云顶新耀-B 公告：自 2025 年 5 月 2 日起，公司英文及中文股份简称不再加“B”标记】云顶新耀-B 称，自 2025 年 5 月 2 日起，公司股份将以新股份简称“EVERESTMED”在联交所买卖。公司股份代号“1952”维持不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042515112694e2172e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042515112694e2172e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","01952","BK1574"],"gpt_icon":0},{"id":"2530947939","title":"云顶新耀-B(01952)：5月2日起英文及中文股份简称将不再加上标记“B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2530947939","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530947939?lang=zh_cn&edition=full","pubTime":"2025-04-25 12:14","pubTimestamp":1745554493,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云顶新耀-B(01952)发布公告，公司恳请股东及潜在投资者注意，自2025年5月2日起，公司的英文及中文股份简称将不再加上标记“B”，而公司股份将以新股份简称“EVEREST MED”(英文)及“云顶新耀”(中文) 在联交所买卖。公司股份代号“1952”维持不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01952","BK1574","BK1161","BK1583"],"gpt_icon":0},{"id":"2530591097","title":"港股异动 | 云顶新耀-B(01952)早盘涨超6% 商业化能力获验证 获批从股票代码中移除“B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2530591097","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530591097?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:43","pubTimestamp":1745545407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，云顶新耀-B早盘涨超6%，截至发稿，涨4.85%，报48.65港元，成交额1.38亿港元。消息面上，4月22日，云顶新耀获得联交所正式批准，将“B”标记从股票代码中移除，这是云顶新耀转向“商业化成熟企业”的重要里程碑，标志着云顶新耀在市值和收入等方面达到了更高标准，商业化能力得到进一步认可。预计将在2025年获得中国国家药品监督管理局完全批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","01952","BK1574"],"gpt_icon":0},{"id":"2530910386","title":"云顶新耀-B盘中异动 早盘股价大涨5.17%报48.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530910386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530910386?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:31","pubTimestamp":1745544708,"startTime":"0","endTime":"0","summary":"2025年04月25日早盘09时31分，云顶新耀-B股票出现波动，股价快速拉升5.17%。截至发稿，该股报48.800港元/股，成交量91.3万股，换手率0.28%，振幅3.02%。云顶新耀-B股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，云顶新耀-B、晶泰控股、博安生物涨幅较大，振幅较大的相关个股有腾盛博药-B、基石药业-B、维亚生物，振幅分别为5.41%、4.67%、4.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425093149a6c75a0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425093149a6c75a0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01952","BK1161","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.everestmedicines.com","stockEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":0.0259},{"period":"3month","weight":0.1784},{"period":"6month","weight":0.3099},{"period":"1year","weight":0.9771},{"period":"ytd","weight":-0.0176}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.1316},{"period":"3month","weight":0.0777},{"period":"6month","weight":0.0988},{"period":"1year","weight":0.2436},{"period":"ytd","weight":0.1354}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"云顶新耀有限公司是一家主要从事创新药及疫苗研发、临床开发、制造及商业化的生物制药公司。该公司已建立跨肾病、抗感染及自身免疫性疾病的产品管线。该公司的产品管线包括用于肾病治疗领域的耐赋康（TARPEYO）、用于治疗包括临床常见的革兰氏阴性菌、革兰氏阳性菌、厌氧菌等多重耐药菌的感染的依嘉（依拉环素）等产品。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.001711},{"month":2,"riseRate":0.4,"avgChangeRate":0.052947},{"month":3,"riseRate":0.4,"avgChangeRate":0.004093},{"month":4,"riseRate":0.2,"avgChangeRate":-0.095155},{"month":5,"riseRate":0.4,"avgChangeRate":-0.015643},{"month":6,"riseRate":0.75,"avgChangeRate":0.281644},{"month":7,"riseRate":0,"avgChangeRate":-0.15054},{"month":8,"riseRate":0.25,"avgChangeRate":-0.139716},{"month":9,"riseRate":0.75,"avgChangeRate":0.086225},{"month":10,"riseRate":0.5,"avgChangeRate":0.00246},{"month":11,"riseRate":0.6,"avgChangeRate":0.110884},{"month":12,"riseRate":0.8,"avgChangeRate":0.201293}],"exchange":"SEHK","name":"云顶新耀","nameEN":"EVEREST MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云顶新耀(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云顶新耀(01952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云顶新耀,01952,云顶新耀股票,云顶新耀股票老虎,云顶新耀股票老虎国际,云顶新耀行情,云顶新耀股票行情,云顶新耀股价,云顶新耀股市,云顶新耀股票价格,云顶新耀股票交易,云顶新耀股票购买,云顶新耀股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云顶新耀(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云顶新耀(01952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}